Cargando…

Evaluating whole‐brain tissue‐property changes in MRI‐negative pharmacoresistant focal epilepsies using MR fingerprinting

OBJECTIVE: We aim to quantify whole‐brain tissue‐property changes in patients with magnetic resonance imaging (MRI)–negative pharmacoresistant focal epilepsy by three‐dimensional (3D) magnetic resonance fingerprinting (MRF). METHODS: We included 30 patients with pharmacoresistant focal epilepsy and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Su, Ting‐Yu, Tang, Yingying, Choi, Joon Yul, Hu, Siyuan, Sakaie, Ken, Murakami, Hiroatsu, Jones, Stephen, Blümcke, Ingmar, Najm, Imad, Ma, Dan, Wang, Zhong Irene
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10107443/ https://www.ncbi.nlm.nih.gov/pubmed/36507762 http://dx.doi.org/10.1111/epi.17488

Ejemplares similares

Radiological and Clinical Value of 7T MRI for Evaluating 3T-Visible Lesions in Pharmacoresistant Focal Epilepsies
por: Wang, Z. Irene, et al.
Publicado: (2021)

Cortical stimulation in pharmacoresistant focal epilepsies
por: Ellrich, Jens
Publicado: (2020)

7T MRI with post-processing for the presurgical evaluation of pharmacoresistant focal epilepsy
por: Chen, Cong, et al.
Publicado: (2021)

An introduction to the mini‐symposium on “The Neuropathology of Focal Human Epilepsy”
por: Blümcke, Ingmar
Publicado: (2021)

Toward a refined genotype–phenotype classification scheme for the international consensus classification of Focal Cortical Dysplasia
por: Blumcke, Ingmar, et al.
Publicado: (2021)

Multimodal Image Integration for Epilepsy Presurgical Evaluation: A Clinical Workflow
por: Jin, Liri, et al.
Publicado: (2021)

Altered structural connectome in non-lesional newly diagnosed focal epilepsy: Relation to pharmacoresistance
por: Kreilkamp, Barbara A.K., et al.
Publicado: (2021)

Genetic variations associated with pharmacoresistant epilepsy
por: Cárdenas-Rodríguez, Noemí, et al.
Publicado: (2020)

Vagal nerve stimulation for pharmacoresistant epilepsy in children
por: Hauptman, Jason S., et al.
Publicado: (2012)

Improving Therapy of Pharmacoresistant Epilepsies: The Role of Fenfluramine
por: Dini, Gianluca, et al.
Publicado: (2022)

Novel noninvasive identification of patient‐specific epileptic networks in focal epilepsies: Linking single‐photon emission computed tomography perfusion during seizures with resting‐state magnetoencephalography dynamics
por: Krishnan, Balu, et al.
Publicado: (2022)

MR Fingerprinting with b‐Tensor Encoding for Simultaneous Quantification of Relaxation and Diffusion in a Single Scan
por: Afzali, Maryam, et al.
Publicado: (2022)

Cytochrome P450-mediated antiseizure medication interactions influence apoptosis, modulate the brain BAX/Bcl-X(L) ratio and aggravate mitochondrial stressors in human pharmacoresistant epilepsy
por: Ghosh, Chaitali, et al.
Publicado: (2022)

Cognitive Processing Impacts High Frequency Intracranial EEG Activity of Human Hippocampus in Patients With Pharmacoresistant Focal Epilepsy
por: Cimbalnik, Jan, et al.
Publicado: (2020)

Past Trauma Is Associated With a Higher Risk of Experiencing an Epileptic Seizure as Traumatic in Patients With Pharmacoresistant Focal Epilepsy
por: Mariotti, Sara, et al.
Publicado: (2021)

Pharmacoresistant Abdominal Seizures in Symptomatic Localization-Related Epilepsy
por: Tushar, Vadakke Puthanveetil, et al.
Publicado: (2021)

The Pharmacoresistant Epilepsy: An Overview on Existant and New Emerging Therapies
por: Fattorusso, Antonella, et al.
Publicado: (2021)

Transporter hypothesis in pharmacoresistant epilepsies. Is it at the central or peripheral level?
por: Czornyj, Liliana, et al.
Publicado: (2021)

Corrigendum: Improving therapy of pharmacoresistant epilepsies: The role of fenfluramine
por: Dini, Gianluca, et al.
Publicado: (2023)

Molecular and subregion mechanisms of episodic memory phenotypes in temporal lobe epilepsy
por: Busch, Robyn M, et al.
Publicado: (2022)

Effect of Oxidative Stress on ABC Transporters: Contribution to Epilepsy Pharmacoresistance
por: Grewal, Gurpreet Kaur, et al.
Publicado: (2017)

A complex systems view on the current hypotheses of epilepsy pharmacoresistance
por: Servilha‐Menezes, Gabriel, et al.
Publicado: (2022)

MRI of focal cortical dysplasia
por: Urbach, Horst, et al.
Publicado: (2021)

A fingerprint of the epileptogenic zone in human epilepsies
por: Grinenko, Olesya, et al.
Publicado: (2018)

Lower fat and better quality diet therapy for children with pharmacoresistant epilepsy
por: Yoon, Jung-Rim, et al.
Publicado: (2013)

‘Hippocampal innate inflammatory gliosis only’ in pharmacoresistant temporal lobe epilepsy
por: Grote, Alexander, et al.
Publicado: (2022)

Limbic network co‐localization predicts pharmacoresistance in dysplasia‐related epilepsy
por: Cohen, Nathan T., et al.
Publicado: (2023)

Different pharmacoresistance of focal epileptic spasms, generalized epileptic spasms, and generalized epileptic spasms combined with focal seizures
por: Takahashi, Yukitoshi, et al.
Publicado: (2021)

Effects of Surgical Side and Site on Mood and Behavior Outcome in Children with Pharmacoresistant Epilepsy
por: Andresen, Elizabeth N., et al.
Publicado: (2014)

Cannabidiol in Pharmacoresistant Epilepsy: Clinical Pharmacokinetic Data From an Expanded Access Program
por: Contin, Manuela, et al.
Publicado: (2021)

Pharmacoresistant Epilepsy in Childhood: Think of the Cerebral Folate Deficiency, a Treatable Disease
por: Mafi, Sarah, et al.
Publicado: (2020)

Gephyrin and CYP2C9 Genetic Polymorphisms in Patients with Pharmacoresistant Epilepsy
por: El-Tallawy, Hamdy N, et al.
Publicado: (2021)

Network Substrates of Centromedian Nucleus Deep Brain Stimulation in Generalized Pharmacoresistant Epilepsy
por: Torres Diaz, Cristina V., et al.
Publicado: (2021)

Multi‐omic strategies applied to the study of pharmacoresistance in mesial temporal lobe epilepsy
por: Bruxel, Estela M., et al.
Publicado: (2021)

Surgical management of epilepsy due to cerebral cavernomas using neuronavigation and intraoperative MR imaging
por: Sommer, Bjoern, et al.
Publicado: (2013)

Incidence and prevalence of major epilepsy-associated brain lesions
por: López-Rivera, Javier A., et al.
Publicado: (2022)

Pharmacoresistant Epilepsy: A Current Update on Non-Conventional Pharmacological and Non-Pharmacological Interventions
por: Sharma, Arun Kumar, et al.
Publicado: (2015)

Bilateral stereotactic lesions and chronic stimulation of the anterior thalamic nuclei for treatment of pharmacoresistant epilepsy
por: Sitnikov, A. R., et al.
Publicado: (2018)

A Clinical-EEG Study of Sleepiness and Psychological Symptoms in Pharmacoresistant Epilepsy Patients Treated with Lacosamide
por: Giorgi, Filippo S., et al.
Publicado: (2013)

Role of DNA Methylation and Adenosine in Ketogenic Diet for Pharmacoresistant Epilepsy: Focus on Epileptogenesis and Associated Comorbidities
por: Chen, Fan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_pgku4h4n13bnjkcs8ud1hrk85s